Format
Sort by

Send to

Choose Destination

Search results

Items: 3

  • Showing results for kiyotake masaki. Your search for Kiyotaka Masaki retrieved no results.
1.

Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice.

Mizuno Y, Yamamotoya T, Nakatsu Y, Ueda K, Matsunaga Y, Inoue MK, Sakoda H, Fujishiro M, Ono H, Kikuchi T, Takahashi M, Morii K, Sasaki K, Masaki T, Asano T, Kushiyama A.

Int J Mol Sci. 2019 Sep 21;20(19). pii: E4680. doi: 10.3390/ijms20194680.

2.

Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice.

Inoue MK, Matsunaga Y, Nakatsu Y, Yamamotoya T, Ueda K, Kushiyama A, Sakoda H, Fujishiro M, Ono H, Iwashita M, Sano T, Nishimura F, Morii K, Sasaki K, Masaki T, Asano T.

Diabetol Metab Syndr. 2019 Jul 22;11:57. doi: 10.1186/s13098-019-0454-6. eCollection 2019.

3.

The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model.

Inoue MK, Yamamotoya T, Nakatsu Y, Ueda K, Inoue Y, Matsunaga Y, Sakoda H, Fujishiro M, Ono H, Morii K, Sasaki K, Masaki T, Suzuki Y, Asano T, Kushiyama A.

Int J Mol Sci. 2018 Dec 10;19(12). pii: E3967. doi: 10.3390/ijms19123967.

Supplemental Content

Loading ...
Support Center